Introduction
============

Pharmacotherapy for hypertension, dyslipidemia, and type 2 diabetes can reduce the risk of major cardiovascular and cerebrovascular events, but adherence is often suboptimal.[@b1-ppa-9-327]--[@b3-ppa-9-327] Medication nonadherence across these cardiometabolic conditions is associated with adverse events, greater inpatient and outpatient health care utilization, and higher health care costs.[@b4-ppa-9-327],[@b5-ppa-9-327]

In patients with these conditions, numerous studies have shown that coexisting depressive symptoms are associated with higher rates of medication nonadherence.[@b6-ppa-9-327]--[@b19-ppa-9-327] However, it is unclear whether these medication nonadherence rates differ across these three comorbid conditions. Although prior condition-specific studies examining the role of depression in nonadherence have indicated different rates of nonadherence,[@b1-ppa-9-327],[@b20-ppa-9-327],[@b21-ppa-9-327] these studies have used different measures of nonadherence in different populations at different times. To our knowledge, no studies have specifically examined the association between depressive symptoms and medication nonadherence in concordant conditions using a consistent measure in the same population at the same time.[@b22-ppa-9-327]

Medication nonadherence may differ by depressive symptom burden because depressed patients tend to have a foreshortened view of the future[@b23-ppa-9-327]--[@b26-ppa-9-327] and may be more sensitive to physical discomfort. Medications for these three conditions differ in their regimen complexity, side effects, out-of-pocket costs, and early consequences of nonadherence. For example, nonadherence to diabetes medications may be driven by regimen complexity (particularly if insulin is required) or its considerable side effects for some patients, despite the short (primarily insulin) and early adverse effects of nonadherence. Nonadherence to antihypertensive medications may also be driven by its sometimes complex regimen or inconvenient side effects. The impact of depressive symptoms on nonadherence to lipid-lowering medications may be more modest because these medications have the least complex regimen (a single statin), the fewest side effects, and typically the lowest out-of-pocket costs.

Using a validated self-report measure that distinguishes extent of medication nonadherence from reasons for nonadherence,[@b27-ppa-9-327] we compared nonadherence rates and the reasons for reported nonadherence among participants with low and high depressive symptom burdens who were prescribed medication for at least one of three cardiometabolic conditions (hypertension, dyslipidemia, or diabetes). Based on prior literature, we expected that the association between depressive symptoms and extent of nonadherence would differ between patients with these different conditions for the reasons noted above. To inform what underlies the extent of nonadherence reported, we also examined the association between depressive symptoms and reasons for nonadherence among the subset of patients reporting nonadherence. These findings can serve to guide interventions to improve adherence using a framework sensitive to the unique barriers presented by different patients, medications, and disease types.

Methods
=======

Study setting and population
----------------------------

This study was approved by the Institutional Review Board of the Durham Veterans Administration Medical Center (VAMC), Durham, NC, USA. A waiver for documentation of informed consent was approved to preserve participant anonymity. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all participants for being included in the study.

In 2012, a randomly selected subset of 1,999 veterans' affairs (VA) patients from a larger claims-based cohort of 7,933 veterans in the Durham VAMC catchment area with one or more of four cardiometabolic conditions (diabetes, hypertension, dyslipidemia, and heart failure) were sent a mailed survey. Veterans were initially selected in the larger claims-based cohort from an initial cohort of 29,368 veterans identified from Durham VAMC medical records. Veterans were excluded if they had no outpatient utilization in 2008 (n=3,001), were receiving outpatient care at other VAMCs (n=11,594), died before the end of the study period (n=518), were younger than 40 years in 2008 (n=173), had a diagnosis for these conditions that could not be confirmed in VA claims data (n=5,363), were seen in outpatient primary care clinics staffed by resident physicians (n=339), had a medication for at least one of these four conditions that could not be confirmed in claims data (n=401), or were missing data for marital status or copayment status (n=46). We restricted the sample to veterans aged 40 years or older because the risk of cardiovascular disease increases markedly with each 20 mmHg increment in systolic blood pressure for adults 40 years and over[@b28-ppa-9-327] and the onset for the majority of type 2 diabetes patients occurs after the age of 40 years. By mailing a survey to a random 1,999 of these 7,933 patients, we were able to link the survey data for respondents back to their VAMC claims data to obtain information on demographic and clinical factors to include as covariates.

Measures
--------

The survey included a validated two-domain self-reported measure of medication nonadherence that assesses extent of nonadherence and reasons for nonadherence.[@b27-ppa-9-327] The three-item nonadherence extent measure asks respondents to complete the following statements using a 7-day recall period: "I took all doses of my \[condition\] medication", "I missed or skipped at least one dose of my \[condition\] medication", and "I was not able to take all of my \[condition\] medication". The five response options measured frequency: never, rarely, sometimes, often, and always.[@b29-ppa-9-327] Participants who reported nonadherence on the extent scale were asked to complete the 21-item measure of reasons for nonadherence in the last 7 days separately for each condition for which they were taking medications (ie, hypertension, dyslipidemia, and type 2 diabetes) using five-point scales anchored by "not at all" and "very much". Patients also completed the validated[@b30-ppa-9-327]--[@b35-ppa-9-327] Mental Health Inventory (MHI)-5 scale developed by Veit and Ware[@b36-ppa-9-327] as a measure of depressive symptomology.

To examine and adjust for demographic differences between survey respondents across cardiometabolic conditions and levels of depressive symptom burden, we constructed covariates for age (\<65 years, 65+ years), sex, race (Caucasian, non-Caucasian, and unreported), marital status (married, divorced/widowed, single/never married, and unknown), copayment status (free VA care or not), number of cardiometabolic conditions (1, 2, 3, or 4), number of other chronic conditions,[@b37-ppa-9-327] and number of VA prescribers (0, 1, 2, 3, or 4+) in 2012 from information VA claims data.

Analysis
--------

All analyses were conducted using Stata/MP (v12.1; Stata-Corp LP, College Station, TX, USA). We did not analyze data for the congestive heart failure patients due to the small sample size. One of the three extent of nonadherence items ("I took all of my doses of \[condition\] medication") was not highly correlated with the other two items (*r*=0.27 and *r*=0.20) as it had been in the initial validation study involving oral administration.[@b27-ppa-9-327] In this self-administration of the measure, that item, which was designed to be reverse-scored to reduce acquiescence bias, produced substantial measurement error, with many participants responding in a way that was inconsistent with the other two items. Thus, we excluded this item. The remaining two items were highly correlated (*r*=0.58) and had skewed distributions, with most respondents responding "never" (ie, perfect adherence). Accordingly, following our prior research, responses of "never" were coded as "adherent", while all other responses were coded as "nonadherent".[@b27-ppa-9-327] Respondents were included in the analysis for nonadherence reasons if at least one extent question was coded as nonadherent. Reasons for nonadherence examined among those reporting nonadherence on the extent scale were treated as individual items and dichotomized, with responses of "not at all" coded as "no", and all others as "yes".[@b27-ppa-9-327]

We calculated a weighted MHI-5 score for respondents who responded to at least four out of five items by taking the mean of all items for which responses were provided. Scores were then scaled from 0 to 100. We assigned MHI-5 scores \<65 and ≥65 as "low" and "high" depressive symptom burden, respectively (based on validity testing of Rumpf et al[@b33-ppa-9-327] against Diagnostic and Statistical Manual of Mental Disorders \[DSM\] IV criteria).

We first compared survey respondents and non-respondents on demographic variables available from the VA claims data (ie, age, sex, marital status, race, copayment status, number of cardiometabolic conditions, and number of VA prescribers in 2012). For each of the three cardiometabolic conditions, we then estimated logistic regression models to compare the odds of nonadherence (ie, anything other than "never" on the extent of nonadherence scale) between respondents with high and low depressive symptom burden adjusting for the previously mentioned demographic variables. Among participants reporting nonadherence in each of the three condition cohorts, we then estimated a logistic regression for each reason for nonadherence, controlling for the same covariates to understand whether the odds of endorsing a reason for nonadherence differed by depressive symptom burden. We corrected for multiple comparisons in the 63 regressions (21 reasons × 3 cohorts) using Benjamini and Hochberg's approach to control for false discovery rate;[@b38-ppa-9-327],[@b39-ppa-9-327] a post-adjusted *P*-value of \<0.05 was considered significant.

Results
=======

Comparison of survey respondents and non-respondents
----------------------------------------------------

We received 1,026 returned surveys of the 1,999 originally mailed (response rate =51.3%). Respondents were more likely than non-respondents to be greater than 65 years of age, Caucasian, married, and required to pay VA copayments ([Table 1](#t1-ppa-9-327){ref-type="table"}). Many survey respondents completed two or all three self-reported medication adherence measures since they had two or more of the three conditions of interest: 415 (40%) completed the hypertension and cholesterol items on the survey; 24 (2%) completed the cholesterol and diabetes items; 44 (4%) completed the hypertension and diabetes items; and 358 (35%) completed items for all three conditions.

Prevalence of nonadherence and association with depressive symptoms
-------------------------------------------------------------------

The unadjusted proportion of participants reporting nonadherence was similar across the three conditions: 37% (n=338) of 917 participants taking antihypertensives, 37% (n=168) of 437 participants taking diabetes medications, and 39% (n=330) of 849 participants taking lipid-lowering medications ([Table 2](#t2-ppa-9-327){ref-type="table"}). The unadjusted difference between the depression symptom burden groups was only signifi-cant among participants taking lipid-lowering medications (46% vs 34%, *P*=0.001). Adjusted analyses were consistent. That is, the odds of nonadherence to medications to manage dyslipidemia were significantly greater (odds ratio \[OR\]: 1.42, *P*=0.025) among participants with depressive symptoms than those without ([Table 3](#t3-ppa-9-327){ref-type="table"}). In contrast, the adjusted odds of nonadherence did not differ by depressive symptoms for participants taking antihypertensives (OR: 1.24, *P*=0.15) or diabetes medications (OR: 1.15, *P*=0.51).

Reasons for nonadherence and association with depressive symptoms
-----------------------------------------------------------------

Among the subset reporting nonadherence, the most frequent reason for not taking medications for all three conditions was "I forgot" ([Table 4](#t4-ppa-9-327){ref-type="table"}), but the proportion endorsing this reason was only significantly different between depressed and non-depressed for nonadherence to lipid-lowering medications (53% vs 38%, *P*=0.01). For hypertension and dyslipidemia medications, the second most frequently endorsed reason was "I ran out of medication", but this was only significantly associated with depressive symptoms in the dyslipidemia cohort. In both hypertension and dyslipidemia cohorts, there were significant differences by depressive symptoms in endorsement of "I was afraid they may affect my sexual performance", "I was worried about taking them for the rest of my life", "I was busy", "They cost a lot of money", "I had other medications to take", "I was feeling too ill to take them", "I was afraid the medication would interact with other medication I take", "I was afraid of becoming dependent on them", and "I was supposed to take them too many times a day". In the diabetes cohort, there were no significant differences by depressive symptoms for any of the 21 reasons in unadjusted or adjusted analyses.

Adjusted results were generally similar to the bivariate associations ([Table 5](#t5-ppa-9-327){ref-type="table"}), although more reasons remained statistically significant between groups with hypertensive medications than dyslipidemia (six reasons vs two reasons). The group differences by depression symptom burden disappeared for the most frequently reported nonadherence reasons.

Discussion
==========

This study represents the first comparison, to our knowledge, of the association between depressive symptoms and self-reported medication nonadherence and reasons for nonadherence across three concordant cardiometabolic conditions. We expected that the association between depressive symptoms and nonadherence and reasons for nonadherence might differ by condition because the individual medication regimens differ among these conditions in terms of regimen complexity, side effects, out-of-pocket costs, and consequences of nonadherence.

Our rates of extent of nonadherence are similar to nonadherence rates from prior condition-specific analyses based on medication refill data,[@b1-ppa-9-327],[@b20-ppa-9-327] but lower than nonadherence rates reported in studies using other self-report measures.[@b12-ppa-9-327],[@b40-ppa-9-327] In our study, depressive symptom burden was significantly associated with extent of nonadherence to lipid-lowering medications but not to nonadherence to antihypertensive or diabetes medications. The finding of no association for antihypertensive or diabetes medications is at odds with other condition-specific studies, which have used different adherence and depression measures (antihypertensive, diabetes).[@b40-ppa-9-327],[@b41-ppa-9-327]--[@b44-ppa-9-327] The lack of an observed difference in our study may be the result of measurement sensitivity (MPR and various self-report), or, in the case of diabetes, small sample size (168 diabetes vs 578 for hypertension and 518 for dyslipidemia). Future research in larger samples should examine the extent of and reasons for nonadherence separately for individuals taking oral agents and those taking insulin. We suspect there are important differences between oral and injectable diabetes medications, but our measure did not address these medication modes independently.

In addition to being novel by assessing medication nonadherence in concordant conditions using a consistent measure in the same population at the same time, this study is also novel because we examined whether the impact of depressive symptoms on reasons for nonadherence differed between these three conditions. We found that some reasons offered for nonadherence varied between participants reporting higher and lower depression symptom burden. Although the overall top reason for nonadherent behavior in all conditions was forgetting, this reason was not significantly different between depressed and non-depressed respondents in any condition. Participants with greater depressive symptom burden taking antihypertensive medications expressed more concerns about the medication, although participants with a higher depressive symptom burden taking dyslipidemia medications were more likely to actually be nonadherent. Cost was also a concern for individuals with a higher depressive symptom burden taking hypertension and dyslipidemia medications, even though it was not one of the most commonly endorsed reasons for any condition. Although many veterans obtain VA medications at no cost or for a relatively low copayment (US\$9 per 30-day supply), participants with a higher depressive burden with these conditions were somewhat more likely to be responsible for copays.

These adjusted results suggest that extent of nonadherence to lipid-lowering medications may have the greatest room for improvement for patients with comorbid depression. Providers may want to assess whether patients who are nonadherent to lipid-lowering medications are concerned about having to take them for their entire lives or out-of-pocket costs because these two reasons were more likely to be endorsed by participants with depressive symptoms. Participants were also concerned about the impact of antihypertensives on their sexual performance[@b45-ppa-9-327] and complexity of their regimen, so these issues should be considered when counseling patients about increasing their adherence. Similar to Laba et al[@b46-ppa-9-327] we assume that medication nonadherence is a multifactorial outcome influenced not only by the patient's affective status, but also by symptom severity, complexity of the medication regimen, number and nuisance value of the medication side effects, short- and medium-term consequences of not taking the medication, and the affordability of the drug to the patient. It is of particular interest that adherence was worst for dyslipidemia, which arguably has the least complex regimen and fewest side effects. Several reasons may explain this result: Elevated cholesterol is relatively asymptomatic; cholesterol levels do not vary significantly over short periods of time; and cholesterol levels cannot be self-monitored. In contrast, elevated blood pressure and blood glucose cause symptoms; values can vary significantly over short periods of time; and patients can self-monitor their blood pressure and blood glucose levels.

There are several limitations to this study. First, these associations between reasons for nonadherence and depressive symptom burden are cross-sectional, and they should not be considered causal relationships. We adjusted for a number of demographic and clinical variables in our analysis, but unobserved covariates (eg, severity of conditions, income, daily pill burden) may have influenced our findings. Second, it is possible that individuals with high vs low depressive burden have different reporting tendencies, such that self-reported information may be more accurate among one group than the other (eg, Tang et al[@b17-ppa-9-327]; but also see Wang et al[@b7-ppa-9-327] Gonzalez et al[@b47-ppa-9-327]). Third, we do not have information about what class(es) of medications our participants were taking for their conditions, which could influence extent of nonadherence and specific reasons for nonadherence. Fourth, we did not have access to medication possession ratios from claims data contemporaneous to this survey, which would have allowed us to compare how the association of depressive symptom burden varies between self-reported medication adherence and refill measures of adherence. Last, the estimated association between depressive symptoms and self-reported medication nonadherence may be subject to survey response bias, since survey responders were more likely to be older, white, and married than non-responders.

Conclusion
==========

This research provides initial evidence demonstrating heterogeneity in both the extent of medication nonadherence and specific reasons for nonadherence among individuals with and without depressive symptoms in three concordant cardiometabolic conditions. Survey respondents with depressive symptoms generally expressed more concerns about medication side effects/interactions and the duration and frequency of taking their medications than participants without depressive symptoms. Our results suggest that clinicians may be able to identify specific medication concerns of participants with depressive symptoms that can serve as intervention targets for achieving improved adherence.

Future research should systematically reckon with the variety of regimens, side effects, and costs of different medications within chronic conditions to observe which factors are medication-specific, which are associated with depressive symptom burden, and how these factors interact. With a framework to structure short- and medium-term costs and rewards for adherence, the heterogeneity in reasons for medication nonadherence across chronic conditions, medication classes, and patient characteristics may begin to form more predictable categories. Similarly, longitudinal studies of variability in reasons for nonadherence and how these reasons fluctuate with the point of pharmaceutical intervention (ie, initiation vs maintenance) and changing depressive symptom burden over time are also needed.[@b29-ppa-9-327] Together, these areas of research will inform development of more effective interventions to improve medication adherence in at-risk patient populations.
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###### 

Comparison of survey responders and non-responders

                                          Completed survey   *P*-value                 
  --------------------------------------- ------------------ ----------- ------ ------ ---------
  Age in years (mean, SD)                 70.0               9.7         69.0   10.7   0.036
  Age (n, %)                                                                           
   \>65 years                             303                29.5        341    35.0   0.010
   40--64 years                           723                70.5        633    65.0   
  Sex (n, %)                                                                           
   Male                                   969                94.4        934    95.9   0.145
   Female                                 57                 5.56        40     4.1    
  Race (n, %)                                                                          
   White                                  687                67.0        569    58.4   \<0.001
   Black                                  290                28.3        369    37.9   
   Other                                  21                 2.1         22     2.3    
   Unknown                                28                 2.7         14     1.4    
  Marital status (n, %)                                                                
   Married                                679                66.2        570    58.5   0.001
   Divorced/widowed                       216                21.0        241    24.7   
   Single/never married                   95                 9.3         101    10.4   
   Unknown                                36                 3.5         62     6.4    
  Pays health care copay (n, %)                                                        
   Yes                                    287                28.0        227    23.3   0.019
   No                                     739                72.0        746    76.6   
   Missing                                0                  0.0         1      0.1    
  Pays prescription copay (n, %)                                                       
   Yes                                    711                69.3        605    62.1   0.001
   No                                     315                30.7        368    37.8   
   Missing                                0                  0.0         1      0.1    
  Gagne comorbidity score (median, IQR)   0.3                1.5         0.0    1.3    0.012
  Number of conditions (mean, SD)         6.39               5.0         6.50   5.0    0.613
  Number of VA prescribers (n, %)                                                      
   0                                      52                 5.1         63     6.5    0.025
   1                                      628                61.2        540    55.4   
   2                                      232                23.6        226    23.2   
   3                                      70                 6.8         80     8.2    
   4                                      44                 4.3         64     6.7    

**Notes:** *P*-values were estimated with two- sample *t*-test for age and number of conditions; with Wilcoxon rank sums for the Gagne Score; and with Fisher's exact test for all others.

**Abbreviations:** IQR, interquartile range; SD, standard deviation; VA, veterans' affairs.

###### 

Unadjusted percent self-reported adherence and nonadherence by condition

  Covariate                  Hypertension   *P*-value   Dyslipidemia   *P*-value   Type 2 diabetes   *P*-value                  
  -------------------------- -------------- ----------- -------------- ----------- ----------------- ----------- ------- ------ -------
  Depressive symptoms                                                                                                           
   MHI \>65 (yes)            59.9           40.1        0.059          54.1        45.9              0.001       58.6    41.4   0.102
   MHI \<65 (no)             65.2           34.8                       65.6        34.4                          64.9    35.1   
  Age (years)                                                                                                                   
   40--64                    59.2           40.8        0.034          54.3        45.7              0.001       58.2    41.8   0.092
   65+                       65.3           34.5                       65.3        34.7                          65.0    35.0   
  Sex                                                                                                                           
   Male                      63.8           36.2        0.068          61.4        38.6              0.264       63.9    36.1   0.009
   Female                    52.7           42.3                       55.6        44.4                          38.5    61.5   
  Race                                                                                                                          
   White                     65.1           34.9        0.139          66.0        34.0              \<0.001     65.8    34.2   0.145
   Black                     58.2           41.8                       51.2        48.3                          56.2    43.8   
   Other                     66.7           33.3                       53.1        46.9                          62.5    37.5   
  Marital                                                                                                                       
   Married                   63.9           36.1        0.390          64.5        35.6              0.013       64.7    35.3   0.389
   Divorced/widowed          61.7           38.3                       52.5        47.5                          58.1    41.9   
   Never married             58.8           41.2                       55.8        44.2                          56.9    43.1   
   Unknown                   100            0.0                        40.0        60.0                          100.0   0.0    
  Pays health care copay                                                                                                        
   Yes                       61.3           38.7        0.797          67.1        32.9              0.058       66.4    33.6   0.528
   No                        63.6           36.4                       58.8        41.2                          61.3    38.7   
   Unknown                   66.7           36.9                                                                                
  Pays prescription copay                                                                                                       
   Yes                       60.9           39.1        0.118          62.0        38.0              0.759       62.9    37.1   0.924
   No                        68.2           31.8                       59.0        41.0                          61.6    38.4   
   Unknown                   66.7           33.3                                                                                
  Number of conditions                                                                                                          
   1                         85.7           14.3        0.458                                        0.792                      0.879
   2                         62.2           37.8                       62.4        37.6                          65.8    34.2   
   3                         64.2           35.8                       60.1        39.9                          61.6    38.4   
   4                         55.6           44.4                       58.8        41.2                          60.7    39.3   
  Number of VA prescribers                                                                                                      
   0                         62.6           37.4        0.278                                        0.433                      0.157
   1                         63.7           36.3                       60.6        39.4                          65.5    34.5   
   2                         63.2           36.8                       57.5        42.5                          63.9    36.1   
   3                         53.9           46.2                       61.8        38.2                          43.6    56.4   
   4                         72.7           27.3                       60.4        39.6                          63.4    36.6   

**Note:** Percentages and *P*-values estimated using Fisher's exact test.

**Abbreviations:** MHI, Mental Health Inventory; VA, veterans' affairs.

###### 

Adjusted self-reported nonadherence by condition

  Condition                        Hypertension n=917   Dyslipidemia n=849   Type 2 diabetes n=437                  
  -------------------------------- -------------------- -------------------- ----------------------- ------- ------ -------
  High depressive symptom burden   1.24                 0.149                1.42                    0.025   1.15   0.512
  Age ≥65 years                    0.77                 0.087                0.74                    0.058   0.84   0.450
  Female                           1.55                 0.139                0.88                    0.706   2.55   0.041
  Race                                                                                                              
   Black                           1.38                 0.045                1.59                    0.005   1.39   0.139
   Other                           0.87                 0.727                1.65                    0.196   0.83   0.75
  Marital status                                                                                                    
   Divorced/widowed                1.03                 0.875                1.55                    0.016   1.23   0.401
   Single/never married            1.03                 0.265                1.21                    0.325   1.01   0.969
  Pays health care copay           1.19                 0.347                0.94                    0.723   0.98   0.938
  Pays prescription copay          1.45                 0.038                1.17                    0.381   1.09   0.72
  Number of conditions                                                                                              
   3                               0.90                 0.464                0.99                    0.944   1.04   0.877
   4                               1.51                 0.254                1.11                    0.792   1.25   0.633
  Number of VA prescribers                                                                                          
   1                               0.88                 0.523                1.34                    0.199   0.82   0.496
   2                               0.87                 0.562                1.40                    0.187   0.73   0.355
   3                               1.33                 0.341                1.05                    0.338   1.81   0.162
   4                               0.63                 0.199                1.16                    0.683   0.83   0.674

**Abbreviations:** OR, odds ratio; VA, veterans' affairs.

###### 

Frequency and percent of reported reasons for nonadherence by depressive symptom burden and condition

  Condition   Hypertension                                                              Dyslipidemia   Type 2 diabetes                                                                                        
  ----------- ------------------------------------------------------------------------- -------------- ----------------- ---- ------- --------- ---- ------- ---- ------- --------- ---- ------- ---- ------- -------
              **Negative expectations or worry**                                                                                                                                                              
  4           I worried about taking them for the rest of my life                       22             12.64             38   29.92   \<0.001   15   9.87    36   26.47   \<0.001   7    8.97    18   26.87   0.070
  10          I was afraid of becoming dependent on them                                10             5.88              15   15.20   0.018     14   9.21    24   17.52   0.012     5    6.49    6    9.09    0.692
  11          I was afraid they may affect my sexual performance                        22             12.64             39   29.77   \<0.001   19   12.18   33   23.24   \<0.001   10   12.82   16   25.53   0.070
  19          I was afraid the medication would interact with other medication I take   17             9.94              21   17.21   0.038     10   6.58    21   15.11   0.030     5    6.49    9    13.85   0.070
              **Poor memory**                                                                                                                                                                                 
  2           I forgot                                                                  78             43.33             70   51.85   0.095     59   37.82   76   52.78   0.011     41   5.62    31   41.89   0.787
  18          I ran out of medication                                                   44             25.73             41   31.78   0.117     31   20.0    39   27.66   0.044     22   28.21   16   24.24   0.436
              **Complex medication regimen**                                                                                                                                                                  
  15          I was supposed to take them too many times a day                          4              2.35              14   11.38   0.013     7    4.64    16   11.68   0.012     4    5.19    8    12.12   0.070
  16          I had other medications to take                                           17             10.06             30   24.39   0.015     15   9.87    24   17.65   0.013     8    10.39   7    10.94   0.692
              **Concerns about drug effects**                                                                                                                                                                 
  3           The medication caused some side effects                                   23             13.07             25   19.84   0.046     22   14.47   33   24.09   0.012     10   12.82   19   27.94   0.070
  17          They make me need to urinate too often                                    30             17.34             35   28.23   \<0.001   20   13.16   28   20.44   0.012     12   15.38   13   19.70   0.184
  20          My (lab measure) was too low                                              32             18.29             19   15.57   0.623     13   8.44    13   9.42    0.716     20   25.64   22   33.33   0.428
  21          I was feeling too ill to take them                                        18             1.47              22   18.18   0.044     11   7.19    24   17.78   0.012     10   12.82   9    13.85   0.353
              **Does not take condition seriously**                                                                                                                                                           
  13          I felt I did not need them                                                24             14.20             20   16.53   0.407     18   11.92   23   16.55   0.081     10   12.99   13   19.70   0.184
  7           I did not have any symptoms of (condition)                                33             19.19             27   22.50   0.033     21   13.82   24   18.05   0.081     18   22.78   17   25.37   0.977
              **Financial burden**                                                                                                                                                                            
  5           They cost a lot of money                                                  27             15.61             32   25.20   \<0.001   14   9.40    25   18.25   \<0.001   10   12.82   11   16.18   0.153
              **Interferes with lifestyle**                                                                                                                                                                   
  1           I was busy                                                                26             14.86             33   25.78   0.015     21   13.82   26   18.71   0.025     14   18.18   13   19.12   0.692
  6           I came home late                                                          32             18.5              28   23.14   0.414     28   18.79   25   18.25   0.559     19   25.33   16   23.19   0.738
  8           I was with friends or family members                                      31             17.92             26   21.49   0.117     20   13.25   24   17.52   0.116     13   16.88   9    13.24   0.911
  9           I was in a public place                                                   20             11.83             18   14.88   0.300     16   10.67   16   11.85   0.523     11   14.29   6    8.96    0.869
  12          The time to take them was between my meals                                18             10.47             18   14.52   0.06      17   11.04   18   12.86   0.287     7    8.97    15   22.39   0.070
  14          I was traveling                                                           40             22.99             26   2.63    0.843     32   21.05   23   16.91   0.716     27   34.62   13   19.40   0.911

**Abbreviation:** FDR-p, false discovery rate *P*-value; Freq, response frequency.

###### 

Adjusted odds of self-reported reasons for nonadherence among participants with high depressive symptom burden

  Condition   Hypertension (n=338)                                                       Dyslipidemia (n=330)   Type 2 diabetes (n=167)                         
  ----------- -------------------------------------------------------------------------- ---------------------- ------------------------- ------ ------- ------ -------
              **Negative expectations/worry**                                                                                                                   
  4           I worried about taking them for the rest of my life                        3.09                   0.011                     3.63   0.021   4.96   0.105
  10          I was afraid of becoming dependent on them                                 2.38                   0.152                     2.13   0.119   1.44   0.818
  11          I was afraid they may affect my sexual performance                         3.09                   0.011                     2.34   0.084   3.41   0.205
  19          I was afraid the medication would interact with other medications I take   2.27                   0.108                     2.64   0.105   2.79   0.391
              **Poor memory**                                                                                                                                   
  2           I forgot                                                                   1.44                   0.263                     1.71   0.116   0.70   0.53
  18          I ran out of medication Complex medication regimen                         1.54                   0.252                     1.61   0.206   0.94   0.979
  15          I was supposed to take them too many times a day                           6.52                   0.017                     2.40   0.185   3.38   0.348
  16          I had other medications to take                                            3.11                   0.011                     1.70   0.282   0.98   0.979
              **Concerns about drug effects**                                                                                                                   
  3           The medication caused some side effects                                    1.42                   0.479                     2.03   0.116   2.88   0.205
  17          They make me need to urinate too often                                     2.33                   0.028                     2.04   0.116   3.10   0.252
  20          My (lab measure) was too low                                               1.07                   0.854                     1.36   0.573   1.57   0.488
  21          I was feeling too ill to take them                                         1.57                   0.386                     2.76   0.084   1.16   0.922
              **Does not take condition seriously**                                                                                                             
  13          I felt I did not need them                                                 1.62                   0.252                     1.45   0.452   1.78   0.445
  7           I did not have any symptoms of (condition)                                 1.26                   0.613                     1.38   0.503   2.54   0.348
              **Financial burden**                                                                                                                              
  5           They cost a lot of money                                                   2.86                   0.011                     3.17   0.042   1.96   0.445
              **Interferes with lifestyle**                                                                                                                     
  1           I was busy                                                                 1.90                   0.126                     1.50   0.402   0.86   0.922
  6           I came home late                                                           1.22                   0.613                     0.91   0.85    0.53   0.445
  8           I was with friends or family members                                       1.20                   0.621                     1.40   0.483   1.02   0.979
  9           I was in a public place                                                    1.31                   0.613                     1.00   0.999   0.64   0.652
  12          The time to take them was between my meals                                 1.31                   0.613                     1.05   0.951   3.81   0.205

**Abbreviations:** FDR-p, false discovery rate *P*-value; OR, odds ratio.
